Sareum Holdings plc (LON:SAR – Get Free Report)’s stock price was up 18% on Wednesday . The stock traded as high as GBX 28.63 ($0.36) and last traded at GBX 28.63 ($0.36). Approximately 664,011 shares changed hands during mid-day trading, a decline of 36% from the average daily volume of 1,038,089 shares. The stock had previously closed at GBX 24.25 ($0.30).
Sareum Price Performance
The firm has a 50 day simple moving average of GBX 22.94 and a two-hundred day simple moving average of GBX 44.87. The stock has a market cap of £20.09 million, a price-to-earnings ratio of -485.00 and a beta of -0.69.
About Sareum
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Recommended Stories
- Five stocks we like better than Sareum
- Investing in Commodities: What Are They? How to Invest in Them
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- 3 Healthcare Dividend Stocks to Buy
- Hilton Demonstrates Asset Light is Right for Investors
- Business Services Stocks Investing
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.
